Literature DB >> 12742894

Vulvovaginal candidiasis.

Jeanne Marrazzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12742894      PMCID： PMC1125958          DOI： 10.1136/bmj.326.7397.993

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Women's use of over-the-counter antifungal medications for gynecologic symptoms.

Authors:  D G Ferris; C Dekle; M S Litaker
Journal:  J Fam Pract       Date:  1996-06       Impact factor: 0.493

Review 2.  Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).

Authors:  M C Watson; J M Grimshaw; C M Bond; J Mollison; A Ludbrook
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Pathogenesis of Recurrent Vulvovaginal Candidiasis.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

4.  Sexual behaviors and other risk factors for Candida vulvovaginitis.

Authors:  B D Reed; D W Gorenflo; B W Gillespie; C L Pierson; P Zazove
Journal:  J Womens Health Gend Based Med       Date:  2000 Jul-Aug

5.  Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.

Authors:  J D Sobel; P S Kapernick; M Zervos; B D Reed; T Hooton; D Soper; P Nyirjesy; M W Heine; J Willems; H Panzer; H Wittes
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

Review 6.  Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

Authors:  J D Sobel; S Faro; R W Force; B Foxman; W J Ledger; P R Nyirjesy; B D Reed; P R Summers
Journal:  Am J Obstet Gynecol       Date:  1998-02       Impact factor: 8.661

7.  Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm.

Authors:  L O Eckert; S E Hawes; C E Stevens; L A Koutsky; D A Eschenbach; K K Holmes
Journal:  Obstet Gynecol       Date:  1998-11       Impact factor: 7.661

8.  Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2002-05-10

9.  Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida.

Authors:  A M Geiger; B Foxman; J D Sobel
Journal:  Genitourin Med       Date:  1995-10

10.  Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes.

Authors:  Ella M de Leon; Scott J Jacober; Jack D Sobel; Betsy Foxman
Journal:  BMC Infect Dis       Date:  2002-01-30       Impact factor: 3.090
  10 in total
  5 in total

Review 1.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

2.  Advances in diagnosing vaginitis: development of a new algorithm.

Authors:  Paul Nyirjesy; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

3.  Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care.

Authors:  Pam Barnes; Rute Vieira; Jayne Harwood; Mayur Chauhan
Journal:  Br J Gen Pract       Date:  2017-12       Impact factor: 5.386

4.  Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions.

Authors:  M E L Consolaro; A Gasparetto; T I E Svidzinski; R M Peralta
Journal:  Mycopathologia       Date:  2006-08       Impact factor: 3.785

5.  Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India.

Authors:  Sujit D Rathod; Jeffrey D Klausner; Karl Krupp; Arthur L Reingold; Purnima Madhivanan
Journal:  Infect Dis Obstet Gynecol       Date:  2012-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.